Skip to main content
Alexander Monto, MD, Gastroenterology, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

AlexanderMontoMD

Gastroenterology • San Francisco, CA

Associate Professor, Medicine, UCSF School of Medicine

Join to view full profile

Dr. Monto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Monto's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Gastroenterology, 1998 - 2001
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1998
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1995 - 1996
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
  • University of California, Santa Cruz
    University of California, Santa CruzB.A, Integrative Biology, 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2025
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • UCSF Haile T. Debas Academy of Medical Educators Teaching Award 2011
  • Department of Veterans Affairs National Service Award 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Role of retroviral restriction factors in the interferon-anpha-mediated suppression of HIV-1 in vivo.
    Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Rauch A, Cavassini M, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Ledergerb, Proceedings of the National Academy of Sciences

Lectures

  • Evaluation and Management of Hepatitis C Patients with Advanced Liver Disease. 
    Geriatric Research, Education, and Clinical Center (GRECC) at the Minneapolis Veterans Affairs
  • Hepatitis C and Diabetes Mellitus. 
    VHA-DoD Diabetes Specialty Practice Group Educators Conference, Salt Lake City, UT
  • Natural History of Hepatitis C Virus: Clinical Consequences and Fibrosis Progression. 
    Department of Veterans Affairs, San Francisco HCRC Pharmacy Preceptorship, San Francisco, CA
  • Join now to see all

Other

  • Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment. 
    Rempel H, Sun B, Calosing C, Abadjian L, Monto A, Pulliam L, PLoS ONE
  • Impaired lymphocyte reactivity as measured by immune function testing in untransplanted patients with cirrhosis. 
    Yee RM, Lehil MS, Rongey C, Shen H, Cozen ML, Shen H, Monto A, Ryan JC, Clinical and Vaccine Immunology
  • Nonresponse to interferon- anpha based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis. 
    Cozen ML, Ryan JC, Shen H, Lerrigo R, Yee RM, Sheen E, Wu R, Monto A, PLoS ONE
  • Join now to see all

Press Mentions

  • VA Extends New Hepatitis C Drugs to All Veterans in Its Health System
    VA Extends New Hepatitis C Drugs to All Veterans in Its Health SystemAugust 10th, 2016

Committees

  • Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - Present

Hospital Affiliations

Dr. Alexander Monto, Dr. Alexander Monto, MD, Dr. A Monto